Encouraging safety and preliminary efficacy analysis from the elacestrant and capivasertib Phase 1b regimen of the ELEVATE study will be presented.The…
Cannes, France, May 20, 2026 (GLOBE NEWSWIRE) -- A shift is underway in the global film industry as creators across…
Patients treated with corabotase showed a rapid onset of action of 0.84 days and peak effect statistically superior to placeboAt Week 24, 60.8% of patients treated with corabotase experienced clinically significant sustained duration of effect…
– Complete response (CR) observed in 70% (50/72) of evaluable patients with low-grade upper tract urothelial cancer (UTUC) who completed…
100% of patients treated with CTA313 achieved an SRI-4 response, with half achieving remission May 14, 2026 11:43 ET |…
MONTREUX, Switzerland, May 7, 2026 /PRNewswire/ -- From April 27-28, 2026, the World Business Council for Sustainable Development (WBCSD) Annual…
BENGALURU, India, May 4, 2026 /PRNewswire/ -- Manipal Hospitals, India's largest pan-India multispecialty hospital network by bed capacity, reinforces its philosophy…
High Impact Session presented at Heart Rhythm Society's Congress in ChicagoFirst time showing results of new Less Invasive approachImprovement in…
Single-dose of miv-cel achieved robust and durable improvements in mobility, reversed disability scores, and eliminated the need for chronic immunotherapies…
April 19, 2026 19:45 ET | Source: Sutro Biopharma, Inc. STRO-004 demonstrates robust and consistent antitumor activity across multiple TF-expressing…